@prefix this: <http://purl.org/np/RAxyys0B68cZCSJFmkcUo69NLHSiP9lfPjsnYjAEIAt7Q> .
@prefix sub: <http://purl.org/np/RAxyys0B68cZCSJFmkcUo69NLHSiP9lfPjsnYjAEIAt7Q#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}
sub:assertion {
   <http://identifiers.org/pubchem.compound/21146529> a biolink:ChemicalEntity ;
    rdfs:label "tenofovir" ;
    biolink:category biolink:ChemicalEntity .
  <http://identifiers.org/pubchem.compound/60877> a biolink:ChemicalEntity ;
    rdfs:label "emtricitabine" ;
    biolink:category biolink:ChemicalEntity .
  <http://identifiers.org/pubchem.compound/64139> a biolink:ChemicalEntity ;
    rdfs:label "Efavirenz" ;
    biolink:category biolink:ChemicalEntity .
  sub:_1 rdf:predicate biolink:treats ;
    rdf:subject <http://identifiers.org/pubchem.compound/60877> ;
    a biolink:Association ;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory ;
    biolink:category biolink:Association ;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7c54b1-b440-4cca-97e8-e5b825413d32> .
  sub:_2 rdf:predicate biolink:treats ;
    rdf:subject <http://identifiers.org/pubchem.compound/21146529> ;
    a biolink:Association ;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory ;
    biolink:category biolink:Association ;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7c54b1-b440-4cca-97e8-e5b825413d32> .
  sub:_3 rdf:predicate biolink:treats ;
    rdf:subject <http://identifiers.org/pubchem.compound/64139> ;
    a biolink:Association ;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory ;
    biolink:category biolink:Association ;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7c54b1-b440-4cca-97e8-e5b825413d32> .
}
sub:provenance {
   sub:assertion prov:generatedAtTime "2022-10-13T12:27:17.243405"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-3668-2627 ;
    prov:wasQuotedFrom """ Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. The tablets are available as a combination or complete regimen for adults and children weighing more than 40 kg.
""" .
  biolink: pav:version "2.3.0" .
}
sub:pubInfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" ;
    npx:hasSignature "QC43ENiIjlTEYXDJywIbRomy7eSDRr1WFG+Xtaq8Yo21dbavUT1HBJJ7T8k72epEvOi1Si3gDNJm9btf0OvKKpZy6JbQlWGJfWsWvx5zHwAxxtjBuNeyQ8gVUsSbK++0MgOtfiK+NEXaw+gqTRfdOiTrRH6gD3zirNB3K9HbRcgA3CNSu7kTDOyWafX4qlg6G9XHknra4DNwZ1MN+ATyj9pCHmsnzeUUx4UeKNosHfXEE69o32OqzHLFxHljqRk1NOBeyqsbTb7wUuNjtMrjnZVfyHJ1/wI1NpsjXHrFiidZLrewlNxbRH94ktxnpxQZ21ntykRV15awIv7cVxxdqg==" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2022-10-13T12:27:17.243405"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-3668-2627 .
}